慢性乙型肝炎抗病毒疗法的当前趋势和进展
Juan Li1,2, Siyi Liu1, Qijuan Zang1
1Department of Infectious Diseases, First Affiliated Teaching Hospital, School of Medicine, Xi'an Jiaotong University, Xi'an, Shaanxi 710061, China.
Chinese medical journal
|June 30, 2024
概括
新的抗病毒药物和免疫疗法对慢性乙型肝炎病毒 (HBV) 感染的功能治愈有希望. 组合疗法可能为这种全球性健康问题提供未来的治疗策略.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
背景情况:
- 慢性乙型肝炎病毒 (HBV) 感染是全球重要的健康问题.
- 目前的治疗方法抑制HBV复制,但由于持续的ccccDNA,病毒DNA整合和免疫功能障碍,无法消除病毒.
- 对慢性HBV的功能性治疗仍然是一个主要的治疗挑战.
研究的目的:
- 审查慢性乙型肝炎治疗的最新进展.
- 讨论当前治疗方法的局限性,并探索实现功能治疗的新方法.
- 为慢性HBV的未来治疗策略提供视角.
主要方法:
- 关于HBV抗病毒药物和免疫调节剂的当前文献的综述.
- 在临床试验中对直接作用的抗病毒药物的分析,包括进入抑制剂,囊组装调节器和RNA干扰.
- 检查免疫调节剂,如TLR激动剂,治疗性疫苗和检查点抑制剂.
主要成果:
- 在开发新型直接作用抗病毒药物和免疫疗法方面取得了重大进展.
- 针对HBV生命周期的不同阶段的新药候选药物正在通过临床试验取得进展.
- 免疫调节剂也正在成为潜在的治疗选择.
结论:
- 实现慢性HBV的功能治疗需要新的治疗策略,超越目前的抑制治疗.
- 新兴的直接作用抗病毒药物和免疫疗法为治愈提供了新的希望.
- 组合疗法可能是未来慢性乙型肝炎治疗的关键策略.
相关概念视频
Retrovirus Life Cycles
45.8K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.8K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K


